ZellBios, headquartered in Luxembourg, is a leading manufacturer of niche Active Pharmaceutical Ingredients (APIs), mostly off-patent, serving the worldwide pharmaceutical markets. ZellBios employs 684 people and has production facilities in Germany, Italy and India. ZellBios is the result of the 2011 combination of Farmabios SpA (Italy) and Pharmazell GmbH (Germany), two highly specialized API players
ZellBios has a unique competitive position, especially in Steroids, Highly Potent Substances, Antineoplastics, 5-ASA and Cysteine derivatives, based on a strong reputation, undisputed know-how and development capabilities, and well established customers' relationships on a global basis. ZellBios also offers custom synthesis services to many pharmaceutical and generic companies
Access to ZellBios' divisions website: